Guyatt G. Cairns J. Churchill D. et al.

Evidence-based medicine: a new approach to teaching the practice of medicine.

Jama. 1992; 268: 2420-2425

The gold standard: the challenge of evidence-based medicine.

Temple University Press, Philadelphia2010Windish D.M. Huot S.J. Green M.L.

Medicine Residents’ Understanding of the Biostatistics and Results in the Medical Literature.

JAMA. 2007; 298: 1010-1022Thiese M.S. Ronna B. Robbins R.B.

Misuse of statistics in surgical literature.

J Thorac Dis. 2016; 8: E726-E730

An investigation of the false discovery rate and the misinterpretation of p-values.

R Soc Open Sci. 2014; 1: 140216

The reproducibility of research and the misinterpretation of p-values.

R Soc Open Sci. 2017; 4: 171085Greenland S. Senn S.J. Rothman K.J. et al.

Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations.

Eur J Epidemiol. 2016; 31: 337-350Hoekstra R. Morey R.D. Rouder J.N. et al.

Robust misinterpretation of confidence intervals.

Psychon Bull Rev. 2014; 21: 1157-1164

Why Most Published Research Findings Are False.

PLOS Med. 2005; 2: e124

A Dirty Dozen: Twelve P-Value Misconceptions.

Semin Hematol. 2008; 45: 135-140Wasserstein R.L. Lazar N.A.

The ASA Statement on p-Values: Context, Process, and Purpose.

Am Stat. 2016; 70: 129-133Amrhein V. Greenland S. McShane B.

Scientists rise up against statistical significance.

Nature. 2019; 567: 305-307

The proposal to lower P value thresholds to. 005.

Jama. 2018; 319: 1429-1430

The p-value requires context, not a threshold.

Am Stat. 2019; 73: 115-117Benjamin D.J. Berger J.O. Johannesson M. et al.

Redefine statistical significance.

Nat Hum Behav. 2018; 2: 6-10

Is It time to ban the p value?.

JAMA Psychiatry. 2019; 76: 1219-1220

Scientific reasoning: the bayesian approach.

Open Court Publishing, Chicao and La Salle (IL)2006: 344

Toward evidence-based medical statistics. 1: the p value fallacy.

Ann Intern Med. 1999; 130: 995-1004

Bayesians and frequentists.

BMJ. 1998; 317: 1151-1160A comparison of the Bayesian and frequentist approaches to estimation. 24. Springer, New York2010Neyman J. Pearson E.S. IX

On the problem of the most efficient tests of statistical hypotheses.

Philos Trans R Soc Lond Ser Contain Pap Math Phys Character. 1933; 231: 289-337

The likelihood principle.

IMS, Hayward (CA)1988: 262Hampson L.V. Whitehead J. Eleftheriou D. et al.

Bayesian methods for the design and interpretation of clinical trials in very rare diseases.

Stat Med. 2014; 33: 4186-4201

Philosophy and the practice of Bayesian statistics.

Br J Math Stat Psychol. 2013; 66: 8-38

Introduction to bayesian statistics.

John Wiley & Sons, Hoboken (NJ)2016van de Schoot R. Depaoli S. King R. et al.

Bayesian statistics and modelling.

Nat Rev Methods Primer. 2021; 1: 1-26Lilford R.J. Thornton J.G. Braunholtz D.

Clinical trials and rare diseases: a way out of a conundrum.

BMJ. 1995; 311: 1621-1625Gelman A. Hill J. Yajima M.

Why we (usually) don’t have to worry about multiple comparisons.

J Res Educ Eff. 2012; 5: 189-211Jansen J.O. Pallmann P. MacLennan G. et al.

Investigators the URT. Bayesian clinical trial designs: Another option for trauma trials?.

J Trauma Acute Care Surg. 2017; 83: 736-741Gsponer T. Gerber F. Bornkamp B. et al.

A practical guide to Bayesian group sequential designs.

Pharm Stat. 2014; 13: 71-80

Prior specification in bayesian statistics: three cautionary tales.

J Theor Biol. 2006; 242: 90-100

Bayesian Analysis Reporting Guidelines.

Nat Hum Behav. 2021; 5: 1282-1291van Doorn J. van den Bergh D. Böhm U. et al.

The JASP guidelines for conducting and reporting a Bayesian analysis.

Psychon Bull Rev. 2021; 28: 813-826Goligher E.C. Tomlinson G. Hajage D. et al.

Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome and posterior probability of mortality benefit in a post hoc Bayesian analysis of a randomized clinical trial.

JAMA. 2018; 320: 2251-2259

The selection of prior distributions by formal rules.

J Am Stat Assoc. 1996; 91: 1343-1370

Objective priors: an introduction for frequentists.

Stat Sci. 2011; 26: 187-202Fayers P.M. Ashby D. Parmar M.K.B.

Tutorial in biostatistics: bayesian data monitoring in clinical trials.

Stat Med. 1997; 16: 1413-1430

Bayes factors.

J Am Stat Assoc. 1995; 90: 773-795

Prior convictions.

J Am Coll Cardiol. 2004; 43: 1929-1939

Using full probability models to compute probabilities of actual interest to decision makers.

Int J Technol Assess Health Care. 2001; 17: 17-26Combes A. Hajage D. Capellier G. et al.

Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome.

N Engl J Med. 2018; 378: 1965-1975Adda J. Decker C. Ottaviani M.

P-hacking in clinical trials and how incentives shape the distribution of results across phases.

Proc Natl Acad Sci. 2020; 117: 13386-13392Head M.L. Holman L. Lanfear R. et al.

The extent and consequences of p-hacking in science.

Plos Biol. 2015; 13: e1002106

Statistics and ethics in medical research: III How large a sample?.

Br Med J. 1980; 281: 1336-1338Freiman J.A. Chalmers T.C. Smith H.A. et al.

The Importance of Beta, the Type II Error, and Sample Size in the Design and Interpretation of the Randomized Controlled Trial: Survey of Two Sets of “Negative” Trials.

in: Medical uses of statistics. 2nd edition. CRC Press, Boca Raton (FL)1992: 357-389Moher D. Dulberg C.S. Wells G.A.

Statistical power, sample size, and their reporting in randomized controlled trials.

JAMA. 1994; 272: 122-124Abrahamyan L. Feldman B.M. Tomlinson G. et al.

Alternative designs for clinical trials in rare diseases.

Am J Med Genet C Semin Med Genet. 2016; 172: 313-331Fox E.E. Holcomb J.B. Wade C.E. et al.PROPPR Study Group

Earlier endpoints are required for hemorrhagic shock trials among severely injured patients.

Shock Augusta Ga. 2017; 47: 567-573Holcomb J.B. Moore E.E. Sperry J.L. et al.

Evidence-based and clinically relevant outcomes for hemorrhage control trauma trials.

Ann Surg. 2021; 273: 395-401